Consistent with the physiological role of Mib1 in modulating SMN, pharmacological inhibition of Mib1 was shown to partially rescue the disease phenotype in a mouse model of SMA (Abera et al., 2016). The gene discussed is SMN1; the disease is proximal spinal muscular atrophy.